|
|
|
|
|
AstraZeneca and Ceram Sign R&D Agreement
AstraZeneca and Ceram Research, a materials development company based in the UK, have signed an agreement whereby Ceram will develop its inorganic-based controlled release technology in a feasibility study for delivering select AstraZeneca compounds. More... |
|
|
|
|
|
|
|
|
Agilent |
Together: It's how we work. It's how we help Pharma Succeed. Look to Agilent for real world solutions that help pharmaceutical companies discover more rapidly and more efficiently.
The Agilent RapidFire High-throughput System and 6550 iFunnel Q-TOF mass spec helped one lab reduce a week of work to 4.5 hours, transforming their productivity. Discover more, and request your free ADME Solutions Guide at our new pharma web page www.agilent.com/chem/togetherADME |
 |
|
Shimadzu |
HS-20 headspace sampler for GC and GCMS
Environmental and pharmaceutical application, forensics, material and food production analyses – Shimadzu’s new HS-20 headspace sampler serves GC and GCMS applications particularly in testing and inspection organizations. Read more: |
 |
|
|
Flexicon Liquid Filling |
Fully automatic aseptic liquid filling system
The FPC50W is an aseptic filling system with full or partial stoppering and crimp capping of vials, delivering fill volumes ranging 0.1ml to 100ml and filling accuracy of ± 0.5%.
Read more |
 |
|
|
|
Pharmapack Europe |
13-14 February 2013, Grande Halle de la Villette, Paris, France
How Innovations in Pharma Packaging and Drug Delivery Technologies Enhance Patient Safety and Compliance. Read more
|
 |
|
|
|
|
What area do you think will see increased regulatory attention and enforcement in 2013? |
|
Foreign APIs |
32% |
|
|
GMP inspections |
19% |
|
|
|
|
Manufacturing processes |
13% |
|
|
|
|
Counterfeit medicines |
28% |
|
|
|
|
Social media and digital marketing |
8% |
|
|
|
|
Biosimilars and generics |
36% |
This week we would like to know...
Which of the following has had the most significant advances in PAT over the last 5 years?

|
|
|
Contact Us |
Click here to contact editorial.
Click here to contact sales. |
|